Latest article
Diabetes sort 2: A ‘superior’ weight reduction drug lowers excessive blood sugar
The National Institute for Health and Care Excellence (NICE) confirmed that semaglutide increases insulin secretion by binding and activating the GLP-1 receptor (glucagon-like peptide-1)....
Sanofi Canada continues to spend money on trendy diabetes analysis to enhance outcomes for...
* Several Canadian research studies were presented at the American Diabetes Association's 81st Annual Scientific Sessions to identify optimal therapies for sustainable diabetes management...